Status:
COMPLETED
Efficacy of a Probiotic Lozenge (Inersan) in Patients With Chronic Periodontitis
Lead Sponsor:
CD Pharma India Pvt. Ltd.
Collaborating Sponsors:
Mahatma Gandhi Post-Graduate Institute of Dental Sciences
Conditions:
Chronic Periodontitis
Eligibility:
All Genders
25-60 years
Phase:
PHASE3
Brief Summary
Periodontal disease is a major cause of tooth loss in humans and is one of the most prevalent diseases associated with bone loss. Following bacterial colonization, the gingiva becomes inflamed leading...
Eligibility Criteria
Inclusion
- Subjects of both sexes
- Patients in the age group of 25-60 years
- Subjects with mild to moderate chronic periodontitis, as defined by probing pocket depths 5-7mm in \> 30 % of the probing sites
- The subjects should have at least 16 remaining natural teeth (minimum of at least 4 teeth per quadrant)
- Subjects in good general health
Exclusion
- No antibiotic therapy in the past 2 months
- Medically compromised patients
- Subjects who are pregnant/ lactating
- Smokers and/or alcoholics.
- Those who had undergone any dental surgical or non-surgical therapy within 6 months prior to the start of the study.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01870362
Start Date
June 1 2013
End Date
July 1 2014
Last Update
July 23 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahatma Gandhi Post Graduate Institute of Dental Sciences (MGPGI)
Puducherry, Puducherry, India, 605006